Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Oct
20
2021
Coverage of FDA’s AI/ML Medical Devices Workshop - Part 3: A Summary of the Panel Discussions Mintz
Oct
1
2013
Energy and Environment Law Update - September 30, 2013 Mintz
Oct
5
2018
Final Opioid Legislation Expands Treatment Options for Medicaid Beneficiaries with Substance Use Disorder Mintz
Oct
17
2018
FDA's Drug Centers Release New Draft Guidance on Quantitative Info in Consumer-Directed Ads Mintz
Dec
13
2018
Some BPCIA Clouds Begin to Clear: FDA Issues Final Plans for March 2020 “Deemed to Be a License” Provision Mintz
May
6
2014
Energy and Environmental Law Update - May 5, 2014 Mintz
Jun
5
2014
Energy Technology Connections - June 2014 Mintz
Aug
13
2014
Office of Inspector General (OIG) Approves Manufacturer’s Direct-to-Patient Discount Sales Program Mintz
Mar
13
2019
Judge Dismisses FCA Claims Against Compounding Pharmacy and Private Equity Firm Owner but Allows the Government to Amend Mintz
Oct
6
2014
FDA Announces More Changes to FSMA (Food Safety and Modernization Act) Implementation Rules Mintz
Oct
31
2014
FDA and the Center for Food Safety Reach Settlement Regarding FDA’s GRAS Rule Mintz
May
14
2019
ML Strategies Health Care Preview Week of May 13, 2019 Mintz
Dec
23
2014
Ho Ho Ho GMO! The 2014 GMO Legislation Scorecard Mintz
Aug
6
2019
Three Things to Learn from Delaware Supreme Court’s Opinion on Board of Director Oversight Duties (Marchand v. Barnhill) Mintz
Jun
2
2015
Big Win for Anti-GMO Groups as Oregon Federal Judge Upholds Jackson County GMO Ban Mintz
Sep
3
2019
Part 2 Proposed Rule Brings Clarity and Reduces Regulatory Burdens for Substance Use Disorder Providers, but Challenges Remain Mintz
Oct
25
2019
The Other Shoe Drops: FDA Withdraws 30-Year-Old Homeopathic Drug Enforcement Policy and Puts Industry on Notice of Further Regulatory Pressure Mintz
Apr
28
2023
Moving Towards MOCRA Implementation: FDA Announces Industry “Listening Session” Mintz
Jun
15
2023
Pharmacy Benefit Managers are on the Federal Government’s Radar: Senate, House, and Agency Proposals Seek to Increase PBM Oversight - Part 2 Mintz
Feb
24
2020
340B Ceiling Price Transparency – HRSA Now Requiring Pharmaceutical Manufacturers to Issue Refunds to Covered Entities for Overcharges Mintz
Mar
5
2020
Clinical Trial Results Will See Daylight After HHS Final Rule Is Set Aside Mintz
May
3
2016
New Compounding Policies from FDA May Affect Hospital and Health System Pharmacy Operations Mintz
Jun
9
2016
Senate Appropriations Bill Targets FDA Rulemaking Agenda Mintz
Oct
5
2023
Courts Continue to Grapple with the Causation Standard for False Claims Act Suits Based on Alleged Kickback Schemes, While the Supreme Court Stays on the Sidelines Mintz
May
5
2020
Rough Seas for COVID-19 Serology Tests Lead to Course Correction by FDA Mintz
Nov
17
2023
Indecent Disclosure: FTC Slams Advertisers and Influencers for Failure to Divulge Material Connections Mintz
Sep
21
2016
Administration’s Biotechnology Working Group Updates Coordinated Framework & Unveils National Strategy Mintz
Nov
15
2016
FDA to Study Social Media Promotion Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins